Rigel Pharmaceuticals Inc (RIGL) bonds
RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30
$42.92−0.81 (-1.85%)
Close on Nov 17, 2026Market cap $801.74MP/E 2.7Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Rigel Pharmaceuticals reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Rigel Pharmaceuticals's 10-Q for the period ended Jun 30, 2026
Rigel Pharmaceuticals's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed. The repayment schedule above comes from the same report.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Line of Credit | $60.00M |
| Revolving Credit Facility | $40.00M |
See a number that looks wrong?